Risperidone Tapering Guidelines for Adolescents

Introduction to Tapering

• The American Academy of Child and Adolescent Psychiatry recommends that children and adolescents with intellectual disabilities or psychiatric conditions may be more sensitive to medication effects and side effects, requiring conservative dosing adjustments 1

Recommended Tapering Protocol

• The tapering process should account for concurrent medications, particularly other CNS depressants, which may require even more gradual tapering 2
• Screen for psychiatric comorbidities and substance use disorders before starting the taper 3

Monitoring Requirements

• Weight monitoring is essential, as risperidone causes significant weight gain in pediatric patients, with a mean weight gain of 5.5 kg at 24 weeks and 8 kg at 48 weeks in open-label studies 1

Adjunctive Strategies to Support Tapering

• Integrating cognitive behavioral therapy (CBT) during the taper significantly increases success rates 3, 2
• Provide patient and family education about withdrawal symptoms versus relapse 3, 2

Critical Pitfalls to Avoid

• Never reduce by a fixed amount at each step—always reduce by a percentage of the current dose to maintain proportional reductions in receptor occupancy 3
• Never rush the taper—the goal is durability, not speed 3
• Never abandon the patient if tapering is unsuccessful—maintain the therapeutic relationship and consider maintenance therapy 3

Realistic Timeline and Expectations

• Expect the taper to take 6-12 months minimum, possibly longer for patients with extended treatment duration or relapse history 3
• Patient and family agreement with the tapering plan is essential for success 3
• Tapers are considered successful as long as the patient is making progress—durability matters more than speed 3